Cite

HARVARD Citation

    Santag, S. et al. (2017). BAY 1143269, a novel MNK1 inhibitor, targets oncogenic protein expression and shows potent anti-tumor activity. Cancer letters. pp. 21-29. [Online]. 
  
Back to record